Constellation Pharmaceuticals Provides Updated Preliminary Data from MANIFEST Clinical Trial with CPI-0610 in Oral and Poster Presentations at ASH

Ads

You May Also Like

Inspyr Therapeutics Appoints Claire Thom, Pharm.D. to Board of Directors

WESTLAKE VILLAGE, Calif., Oct. 12, 2016 (GLOBE NEWSWIRE) -- Inspyr Therapeutics, Inc. (OTCQB:NSPX), a ...

Incysus Granted European Patent Covering its Drug Resistant Immunotherapy (DRI) Technology

HAMILTON, Bermuda, April 12, 2017 (GLOBE NEWSWIRE) -- Incysus, Ltd., a biopharmaceutical company focused ...